Department of Biomaterials Science, College of Natural Resources & Life Science/Life and Industry Convergence Research Institute, Pusan National University, 50 Cheonghak-ri, Samnangjin-eup Miryang-si, Gyeongsangnam-do, Miryang, 627-706, Korea.
J Mater Sci Mater Med. 2014 Jun;25(6):1519-30. doi: 10.1007/s10856-014-5182-8. Epub 2014 Feb 28.
Cellulose is one of the most widespread biomolecules in nature and has been exploited in various applications including scaffolding, tissue engineering, and tissue formation. To evaluate the biocompatibility of cellulose film manufactured from Styela clava tunics (SCT-CF), these films were implanted in Sprague-Dawley (SD) rats for various lengths of time, after which they were subjected to mechanical and biological analyses. The cellulose powders (12-268 m) obtained from SCT was converted into films via casting methods without adding any additives. SCT-CF contained about 98 % α-cellulose and very low concentrations of ββ-cellulose. Additionally, the crystallinity index (CrI) of SCT-CF was lower (10.71 %) than that of wood pulp-cellulose films (WP-CF) (33.78 %). After implantation for 90 days, the weight loss and formation of surface corrugations were greater in SCT-CF than that of WP-CF, while the surface roughness was significantly higher in WP-CF than SCT-CF. However, there were no differences in the number of white blood cells between SCT-CF implanted rats and vehicle implanted rats. The level of metabolic enzymes representing liver and kidney toxicity in the serum of SCT-CF implanted rats was maintained at levels consistent with vehicle implanted rats. Moreover, no significant alteration of the epidermal hyperplasia, inflammatory cell infiltration, redness, and edema were observed in SD rats implanted with SCT-CF. Taken together, these results indicate that SCT-CF showed good degradability and non-toxicity without inducing an immune response in SD rats. Further, the data presented here constitute strong evidence that SCT-CF has the potential for use as a powerful biomaterial for medical applications including stitching fiber, wound dressing, scaffolding, absorbable hemostats and hemodialysis membrane.
纤维素是自然界中分布最广泛的生物分子之一,已被广泛应用于支架、组织工程和组织形成等各种应用。为了评估从龙头鱼(Styela clava)中提取的纤维素薄膜(SCT-CF)的生物相容性,将这些薄膜植入 Sprague-Dawley(SD)大鼠体内不同时间,然后对其进行力学和生物学分析。通过浇铸法将从 SCT 获得的纤维素粉末(12-268 m)转化为薄膜,没有添加任何添加剂。SCT-CF 含有约 98%的 α-纤维素和非常低浓度的 β-纤维素。此外,SCT-CF 的结晶度指数(CrI)比木浆纤维素薄膜(WP-CF)(33.78%)低(10.71%)。植入 90 天后,SCT-CF 的重量损失和表面波纹的形成大于 WP-CF,而 WP-CF 的表面粗糙度明显高于 SCT-CF。然而,SCT-CF 植入大鼠和载体植入大鼠的白细胞数量没有差异。SCT-CF 植入大鼠血清中代表肝毒性和肾毒性的代谢酶的水平保持在与载体植入大鼠一致的水平。此外,在植入 SCT-CF 的 SD 大鼠中未观察到表皮增生、炎症细胞浸润、发红和水肿的明显改变。综上所述,这些结果表明 SCT-CF 表现出良好的降解性和无毒性,不会在 SD 大鼠中引起免疫反应。此外,本文提供的数据有力地证明了 SCT-CF 具有作为一种强大的生物材料用于医学应用的潜力,包括缝合纤维、伤口敷料、支架、可吸收止血剂和血液透析膜。